News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
Swiss Fine Drug Firms Pfizer Inc. (JOBS), Eli Lilly and Company (JOBS), Bayer AG (JOBS) $5.7M for Price-Fixing
December 1, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
AP -- The Swiss branches of Pfizer Inc., Eli Lilly & Co. and Bayer AG were fined a total of 5.7 million francs ($5.7 million) by competition regulators on Tuesday for alleged price fixing of drugs for erectile dysfunction.
Twitter
LinkedIn
Facebook
Email
Print
Legal
Regulatory
Europe
Pfizer
Eli Lilly and Company
MORE ON THIS TOPIC
Approvals
Regeneron racks up another first as FDA greenlights generalized myasthenia gravis RNA drug
November 19, 2026
·
3 min read
·
Heather McKenzie
Insights
The untapped potential of drug repurposing
November 19, 2026
·
1 min read
·
Jennifer C. Smith-Parker
Job Trends
Ramping up: 3 biotechs growing their workforce after series C raises
November 19, 2026
·
4 min read
·
Angela Gabriel
Approvals
GSK nabs FDA greenlight for second lung cancer asset from Nuvalent buy
November 18, 2026
·
2 min read
·
Tristan Manalac